Advances in the development of therapeutic strategies against COVID-19 and perspectives in the drug design for emerging SARS-CoV-2 variants
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Advances in the development of therapeutic strategies against COVID-19 and perspectives in the drug design for emerging SARS-CoV-2 variants
Authors
Keywords
SARS-CoV-2, COVID-19 pandemic, Therapeutic strategies, Drug target, SARS-CoV-2 variants
Journal
Computational and Structural Biotechnology Journal
Volume 20, Issue -, Pages 824-837
Publisher
Elsevier BV
Online
2022-02-01
DOI
10.1016/j.csbj.2022.01.026
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Omicron Variant (B.1.1.529): Infectivity, Vaccine Breakthrough, and Antibody Resistance
- (2022) Jiahui Chen et al. Journal of Chemical Information and Modeling
- Recent Developments on Therapeutic and Diagnostic Approaches for COVID-19
- (2021) Joydeb Majumder et al. AAPS Journal
- Mechanism of SARS-CoV-2 polymerase stalling by remdesivir
- (2021) Goran Kokic et al. Nature Communications
- Catechin and curcumin interact with S protein of SARS-CoV2 and ACE2 of human cell membrane: insights from computational studies
- (2021) Atala B. Jena et al. Scientific Reports
- α1-Antitrypsin deficiency and the risk of COVID-19: an urgent call to action
- (2021) Chengliang Yang et al. Lancet Respiratory Medicine
- Efficacy of canakinumab in mild or severe COVID‐19 pneumonia
- (2021) Falasca Katia et al. Immunity Inflammation and Disease
- Simultaneous quantification of seven repurposed COVID-19 drugs remdesivir (plus metabolite GS-441524), chloroquine, hydroxychloroquine, lopinavir, ritonavir, favipiravir and azithromycin by a two-dimensional isotope dilution LC–MS/MS method in human serum
- (2021) Katharina Habler et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- EGCG, a Green Tea Catechin, as a Potential Therapeutic Agent for Symptomatic and Asymptomatic SARS-CoV-2 Infection
- (2021) Mukesh Chourasia et al. MOLECULES
- Antibody Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7
- (2021) Pengfei Wang et al. NATURE
- A small molecule compound with an indole moiety inhibits the main protease of SARS-CoV-2 and blocks virus replication
- (2021) Shin-ichiro Hattori et al. Nature Communications
- Identification of ebselen and its analogues as potent covalent inhibitors of papain-like protease from SARS-CoV-2
- (2021) Ewelina Weglarz-Tomczak et al. Scientific Reports
- Effective drugs used to combat SARS-CoV-2 infection and the current status of vaccines
- (2021) Annoor Awadasseid et al. BIOMEDICINE & PHARMACOTHERAPY
- N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2
- (2021) Matthew McCallum et al. CELL
- Transmission, infectivity, and neutralization of a spike L452R SARS-CoV-2 variant
- (2021) Xianding Deng et al. CELL
- SARS-CoV-2 spike protein dictates syncytium-mediated lymphocyte elimination
- (2021) Zhengrong Zhang et al. CELL DEATH AND DIFFERENTIATION
- Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization
- (2021) Pengfei Wang et al. Cell Host & Microbe
- β-D-N 4-hydroxycytidine (NHC) Inhibits SARS-CoV-2 Through Lethal Mutagenesis But Is Also Mutagenic To Mammalian Cells
- (2021) Shuntai Zhou et al. JOURNAL OF INFECTIOUS DISEASES
- Insights into SARS-CoV-2’s Mutations for Evading Human Antibodies: Sacrifice and Survival
- (2021) Binquan Luan et al. JOURNAL OF MEDICINAL CHEMISTRY
- Drugs that inhibit TMEM16 proteins block SARS-CoV-2 spike-induced syncytia
- (2021) Luca Braga et al. NATURE
- Alpha-1 antitrypsin deficiency severity and the risk of COVID-19: A Portuguese cohort
- (2021) Nuno Faria et al. RESPIRATORY MEDICINE
- Small molecule screening identified cepharanthine as an inhibitor of porcine reproductive and respiratory syndrome virus infection in vitro by suppressing integrins/ILK/RACK1/PKCα/NF-κB signalling axis
- (2021) Chao Yang et al. VETERINARY MICROBIOLOGY
- A super-potent tetramerized ACE2 protein displays enhanced neutralization of SARS-CoV-2 virus infection
- (2021) Ami Miller et al. Scientific Reports
- Efficacy of GC-376 against SARS-CoV-2 virus infection in the K18 hACE2 transgenic mouse model
- (2021) C. Joaquín Cáceres et al. Scientific Reports
- Potential anti-COVID-19 agents, cepharanthine and nelfinavir, and their usage for combination treatment
- (2021) Hirofumi Ohashi et al. iScience
- Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum
- (2021) Chang Liu et al. CELL
- The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies
- (2021) Richard Copin et al. CELL
- Impact of the Delta variant on vaccine efficacy and response strategies
- (2021) Lianlian Bian et al. Expert Review of Vaccines
- Glycosylation is a key in SARS-CoV-2 infection
- (2021) Celso A. Reis et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization
- (2021) Delphine Planas et al. NATURE
- SARS-CoV-2 variants, spike mutations and immune escape
- (2021) William T. Harvey et al. NATURE REVIEWS MICROBIOLOGY
- Traditional Chinese Medicine (TCM) in the treatment of COVID-19 and other viral infections: Efficacies and mechanisms
- (2021) Kai Huang et al. PHARMACOLOGY & THERAPEUTICS
- Postinfection treatment with a protease inhibitor increases survival of mice with a fatal SARS-CoV-2 infection
- (2021) Chamandi S. Dampalla et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Translational shutdown and evasion of the innate immune response by SARS-CoV-2 NSP14 protein
- (2021) Jack Chun-Chieh Hsu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- SARS-CoV-2 infection in alpha1-antitrypsin deficiency
- (2021) Carolin V. Schneider et al. RESPIRATORY MEDICINE
- A broadly neutralizing humanized ACE2-targeting antibody against SARS-CoV-2 variants
- (2021) Yanyun Du et al. Nature Communications
- Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting diverse and conserved epitopes
- (2021) Dapeng Sun et al. Nature Communications
- Correlates of SARS-CoV-2 Variants on Deaths, Case Incidence and Case Fatality Ratio among the Continents for the Period of 1 December 2020 to 15 March 2021
- (2021) Wajdy J. Al-Awaida et al. Genes
- SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution
- (2021) Jiří Zahradník et al. Nature Microbiology
- Identification of SARS-CoV-2–induced pathways reveals drug repurposing strategies
- (2021) Namshik Han et al. Science Advances
- A Minireview of the Promising Drugs and Vaccines in Pipeline for the Treatment of COVID-19 and Current Update on Clinical Trials
- (2021) Jeyanthi Venkadapathi et al. Frontiers in Molecular Biosciences
- Pharmacology and Adverse Events of Emergency-Use Authorized Medication in Moderate to Severe COVID-19
- (2021) Jen-Yu Hsu et al. Pharmaceuticals
- Abbreviated Profile of Drugs (APOD): modeling drug safety profiles to prioritize investigational COVID-19 treatments
- (2021) Chaitanya N. Hiremath Heliyon
- OMICRON (B.1.1.529): A new SARS‐CoV‐2 variant of concern mounting worldwide fear
- (2021) Vikram Thakur et al. JOURNAL OF MEDICAL VIROLOGY
- Characterization of the non-covalent interaction between the PF-07321332 inhibitor and the SARS-CoV-2 main protease
- (2021) Marina Macchiagodena et al. JOURNAL OF MOLECULAR GRAPHICS & MODELLING
- Traditional Chinese medicine as an adjunctive therapy for mild and common COVID-19
- (2021) Xiaozheng Wu et al. MEDICINE
- Discovery, Development, and Patent Trends on Molnupiravir: A Prospective Oral Treatment for COVID-19
- (2021) Mohd. Imran et al. MOLECULES
- Cepharanthine Suppresses Herpes Simplex Virus Type 1 Replication Through the Downregulation of the PI3K/Akt and p38 MAPK Signaling Pathways
- (2021) Yao Liu et al. Frontiers in Microbiology
- The Effect of Anakinra in Hospitalized Patients with COVID-19: An Updated Systematic Review and Meta-Analysis
- (2021) Konstantinos G. Kyriakoulis et al. Journal of Clinical Medicine
- Emerging SARS-CoV-2 Variants: A Review of Its Mutations, Its Implications and Vaccine Efficacy
- (2021) Sindhu Ramesh et al. Vaccines
- Baricitinib as potential treatment for 2019-nCoV acute respiratory disease
- (2020) Peter Richardson et al. LANCET
- Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury
- (2020) Clark D Russell et al. LANCET
- COVID-19: combining antiviral and anti-inflammatory treatments
- (2020) Justin Stebbing et al. LANCET INFECTIOUS DISEASES
- Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury
- (2020) Yingxia Liu et al. Science China-Life Sciences
- The COVID‐19 epidemic
- (2020) Thirumalaisamy P. Velavan et al. TROPICAL MEDICINE & INTERNATIONAL HEALTH
- The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2
- (2020) Nature Microbiology
- Convalescent plasma in Covid-19: Possible mechanisms of action
- (2020) Manuel Rojas et al. AUTOIMMUNITY REVIEWS
- Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
- (2020) Alexandra C. Walls et al. CELL
- Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion
- (2020) Shuai Xia et al. CELL RESEARCH
- Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia (Trial Version 7)
- (2020) CHINESE MEDICAL JOURNAL
- Detectable serum SARS-CoV-2 viral load (RNAaemia) is closely correlated with drastically elevated interleukin 6 (IL-6) level in critically ill COVID-19 patients
- (2020) Xiaohua Chen et al. CLINICAL INFECTIOUS DISEASES
- Cytokine storm intervention in the early stages of COVID-19 pneumonia
- (2020) Xinjuan Sun et al. CYTOKINE & GROWTH FACTOR REVIEWS
- The pivotal link between ACE2 deficiency and SARS-CoV-2 infection
- (2020) Paolo Verdecchia et al. European Journal of Internal Medicine
- Ruxolitinib in treatment of severe coronavirus disease 2019 (COVID-19): A multicenter, single-blind, randomized controlled trial
- (2020) Yang Cao et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Scientific research progress of COVID‐19/SARS‐CoV‐2 in the first five months
- (2020) Hua Li et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Characteristics of patients with coronavirus disease (COVID‐19) confirmed using an IgM‐IgG antibody test
- (2020) Jiajia Xie et al. JOURNAL OF MEDICAL VIROLOGY
- Emerging SARS-CoV-2 mutation hot spots include a novel RNA-dependent-RNA polymerase variant
- (2020) Maria Pachetti et al. Journal of Translational Medicine
- Comparison of SARS-CoV-2 spike protein binding to ACE2 receptors from human, pets, farm animals, and putative intermediate hosts
- (2020) Xiaofeng Zhai et al. JOURNAL OF VIROLOGY
- Impact of corticosteroid therapy on outcomes of persons with SARS-CoV-2, SARS-CoV, or MERS-CoV infection: a systematic review and meta-analysis
- (2020) Huan Li et al. LEUKEMIA
- Structure of replicating SARS-CoV-2 polymerase
- (2020) Hauke S. Hillen et al. NATURE
- Remdesivir for the Treatment of Covid-19 — Preliminary Report
- (2020) John H. Beigel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Remdesivir: Review of pharmacology, pre‐clinical data and emerging clinical experience for COVID‐19
- (2020) Sarah CJ Jorgensen et al. PHARMACOTHERAPY
- Cell entry mechanisms of SARS-CoV-2
- (2020) Jian Shang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effective treatment of severe COVID-19 patients with tocilizumab
- (2020) Xiaoling Xu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Vulnerabilities in coronavirus glycan shields despite extensive glycosylation
- (2020) Yasunori Watanabe et al. Nature Communications
- SARS-CoV-2 Infections and ACE2: Clinical Outcomes Linked With Increased Morbidity and Mortality in Individuals With Diabetes
- (2020) Alexander G. Obukhov et al. DIABETES
- Beneficial impact of Baricitinib in COVID-19 moderate pneumonia; multicentre study
- (2020) Fabrizio Cantini et al. JOURNAL OF INFECTION
- Mutational spectra of SARS‐CoV‐2 orf1ab polyprotein and signature mutations in the United States of America
- (2020) Shuvam Banerjee et al. JOURNAL OF MEDICAL VIROLOGY
- Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study
- (2020) Abdo A. Elfiky LIFE SCIENCES
- Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- Cepharanthine: a review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19
- (2020) Moshe Rogosnitzky et al. Pharmacological Reports
- Candidate drugs against SARS-CoV-2 and COVID-19
- (2020) Dwight L. McKee et al. PHARMACOLOGICAL RESEARCH
- Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2)
- (2020) Li Runfeng et al. PHARMACOLOGICAL RESEARCH
- Use of MRI for Personalized Treatment of More Aggressive Tumors
- (2020) Riham H. El Khouli et al. RADIOLOGY
- Morphogenesis and cytopathic effect of SARS-CoV-2 infection in human airway epithelial cells
- (2020) Na Zhu et al. Nature Communications
- A Review on Remdesivir: A Possible Promising Agent for the Treatment of COVID-19
- (2020) Seyed MohammadReza Hashemian et al. Drug Design Development and Therapy
- RdRp mutations are associated with SARS-CoV-2 genome evolution
- (2020) Doğa Eskier et al. PeerJ
- Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies
- (2020) Yujun Tang et al. Frontiers in Immunology
- The COVID-19 Cytokine Storm; What We Know So Far
- (2020) Dina Ragab et al. Frontiers in Immunology
- Outcomes and biomarker analyses among patients with COVID-19 treated with interleukin 6 (IL-6) receptor antagonist sarilumab at a single institution in Italy
- (2020) Vincenzo Montesarchio et al. Journal for ImmunoTherapy of Cancer
- Bioactive natural compounds against human coronaviruses: a review and perspective
- (2020) Yanfang Xian et al. Acta Pharmaceutica Sinica B
- Pidotimod in paucisymptomatic SARS-CoV2 infected patients
- (2020) Claudio Ucciferri et al. Mediterranean Journal of Hematology and Infectious Diseases
- Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19
- (2020) Jeong Seok Lee et al. Science Immunology
- Dexamethasone, pro‐resolving lipid mediators and resolution of inflammation in COVID‐19
- (2020) Evangelos Andreakos et al. ALLERGY
- Syncytia formation by SARS‐CoV‐2 infected cells
- (2020) Julian Buchrieser et al. EMBO JOURNAL
- Inflammation Triggered by SARS-CoV-2 and ACE2 Augment Drives Multiple Organ Failure of Severe COVID-19: Molecular Mechanisms and Implications
- (2020) Masae Iwasaki et al. INFLAMMATION
- Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19
- (2020) Bruno M. Tomazini et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19
- (2020) et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Discovery of novel pyrazole derivatives as a potent anti‐inflammatory agent in RAW264.7 cells via inhibition of NF‐ĸB for possible benefit against SARS‐CoV‐2
- (2020) Anup Masih et al. JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY
- Impact of Hydroxychloroquine/Chloroquine in COVID-19 Therapy: Two Sides of the Coin
- (2020) Urooj Fatima et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial
- (2020) Francesco Perrone et al. Journal of Translational Medicine
- Effect of combination antiviral therapy on hematological profiles in 151 adults hospitalized with severe coronavirus disease 2019
- (2020) Xin Li et al. PHARMACOLOGICAL RESEARCH
- Baricitinib improves respiratory function in patients treated with corticosteroids for SARS-CoV-2 pneumonia: an observational cohort study
- (2020) Jose Luis Rodriguez-Garcia et al. RHEUMATOLOGY
- Mechanisms of SARS-CoV-2 transmission and pathogenesis
- (2020) Andrew G. Harrison et al. TRENDS IN IMMUNOLOGY
- Analysis of the SARS-CoV-2 spike protein glycan shield reveals implications for immune recognition
- (2020) Oliver C. Grant et al. Scientific Reports
- Reflections on treatment of COVID-19 with traditional Chinese medicine
- (2020) Hua Luo et al. Chinese Medicine
- Strategies for Targeting SARS CoV-2: Small Molecule Inhibitors—The Current Status
- (2020) Narasimha M. Beeraka et al. Frontiers in Immunology
- Role of monoclonal antibody drugs in the treatment of COVID-19
- (2020) Claudio Ucciferri et al. World Journal of Clinical Cases
- Synergism of TNF-α and IFN-γ Triggers Inflammatory Cell Death, Tissue Damage, and Mortality in SARS-CoV-2 Infection and Cytokine Shock Syndromes
- (2020) Rajendra Karki et al. CELL
- A comprehensive review on sarilumab in COVID-19
- (2020) Sajad Khiali et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- The deregulated immune reaction and cytokines release storm (CRS) in COVID-19 disease
- (2020) Ritu Pasrija et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- COVID-19: Cytokine storm modulation/blockade with oral polyvalent immunoglobulins (PVIG, KMP01D): A potential and safe therapeutic agent (Primum nil nocere)
- (2020) Laura M. Sly et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Canakinumab as treatment for COVID-19-related pneumonia: a prospective case-control study
- (2020) Daniele Generali et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19
- (2020) Andre C. Kalil et al. NEW ENGLAND JOURNAL OF MEDICINE
- EGYVIR: An immunomodulatory herbal extract with potent antiviral activity against SARS-CoV-2
- (2020) Wael H. Roshdy et al. PLoS One
- Immune suppression in the early stage of COVID-19 disease
- (2020) Wenmin Tian et al. Nature Communications
- SARS-CoV-2 receptor ACE2 is co-expressed with genes related to transmembrane serine proteases, viral entry, immunity and cellular stress
- (2020) Wasco Wruck et al. Scientific Reports
- SARS-CoV-2: Structure, Biology, and Structure-Based Therapeutics Development
- (2020) Mei-Yue Wang et al. Frontiers in Cellular and Infection Microbiology
- Intestinal Transcriptome Analysis Reveals Soy Derivative-Linked Changes in Atlantic Salmon
- (2020) Viswanath Kiron et al. Frontiers in Immunology
- COVID-19 : encore une place pour le tocilizumab ?
- (2020) Q. Richier et al. REVUE DE MEDECINE INTERNE
- Coronavirus envelope protein: current knowledge
- (2019) Dewald Schoeman et al. Virology Journal
- XueBiJing Injection Versus Placebo for Critically Ill Patients With Severe Community-Acquired Pneumonia
- (2019) Yuanlin Song et al. CRITICAL CARE MEDICINE
- Cepharanthine: An update of its mode of action, pharmacological properties and medical applications
- (2019) Christian Bailly PHYTOMEDICINE
- Immunostimulants in respiratory diseases: focus on Pidotimod
- (2019) Francesca Puggioni et al. MULTIDISCIPLINARY RESPIRATORY MEDICINE
- Corticosteroid Therapy for Critically Ill Patients with Middle East Respiratory Syndrome
- (2018) Yaseen M. Arabi et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Efficacy and safety of Xuebijing injection (a Chinese patent) for sepsis: A meta-analysis of randomized controlled trials
- (2018) Chengyu Li et al. JOURNAL OF ETHNOPHARMACOLOGY
- The mechanism of resistance to favipiravir in influenza
- (2018) Daniel H. Goldhill et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mechanical Ventilation: State of the Art
- (2017) Tài Pham et al. MAYO CLINIC PROCEEDINGS
- Object class segmentation of RGB-D video using recurrent convolutional neural networks
- (2017) Mircea Serban Pavel et al. NEURAL NETWORKS
- Pidotimod: A Reappraisal
- (2017) P. Riboldi et al. INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY
- Interleukin 18 (IL-18) as a target for immune intervention
- (2016) Sebastian Wawrocki et al. ACTA BIOCHIMICA POLONICA
- Halofuginone — The Multifaceted Molecule
- (2015) Mark Pines et al. MOLECULES
- Severe acute respiratory syndrome coronavirus E protein transports calcium ions and activates the NLRP3 inflammasome
- (2015) Jose L. Nieto-Torres et al. VIROLOGY
- The Coronavirus Nucleocapsid Is a Multifunctional Protein
- (2014) Ruth McBride et al. Viruses-Basel
- Inhibition of NF- B-Mediated Inflammation in Severe Acute Respiratory Syndrome Coronavirus-Infected Mice Increases Survival
- (2013) M. L. DeDiego et al. JOURNAL OF VIROLOGY
- Evolution of JAK-STAT Pathway Components: Mechanisms and Role in Immune System Development
- (2012) Clifford Liongue et al. PLoS One
- Mechanisms of Coronavirus Cell Entry Mediated by the Viral Spike Protein
- (2012) Sandrine Belouzard et al. Viruses-Basel
- Influenza Virus–Cytokine‐Protease Cycle in the Pathogenesis of Vascular Hyperpermeability in Severe Influenza
- (2010) Siye Wang et al. JOURNAL OF INFECTIOUS DISEASES
- A structural analysis of M protein in coronavirus assembly and morphology
- (2010) Benjamin W. Neuman et al. JOURNAL OF STRUCTURAL BIOLOGY
- Canakinumab
- (2010) Eugen Dhimolea mAbs
- Exacerbated Innate Host Response to SARS-CoV in Aged Non-Human Primates
- (2010) Saskia L. Smits et al. PLoS Pathogens
- The Nuclear Factor NF- B Pathway in Inflammation
- (2009) T. Lawrence Cold Spring Harbor Perspectives in Biology
- Tocilizumab: The first interleukin-6-receptor inhibitor
- (2008) Anthony Sebba AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search